Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience

In the first part of this article, the anonymous patient diagnosed with leukocyte adhesion deficiency type 1 (LAD-1) and pyoderma gangrenosum (PG) discusses her experience of her medical history and treatment in a foreign country during her pregnancy and the coronavirus disease-19 (COVID-19) pandemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Opalińska, Aleksandra, Burdacki, Adrian, Kwaśniak, Konrad, Pogoda, Katarzyna, Tabarkiewicz, Jacek, Reich, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939102/
https://www.ncbi.nlm.nih.gov/pubmed/33686591
http://dx.doi.org/10.1007/s13555-021-00507-x
_version_ 1783661686185525248
author Opalińska, Aleksandra
Burdacki, Adrian
Kwaśniak, Konrad
Pogoda, Katarzyna
Tabarkiewicz, Jacek
Reich, Adam
author_facet Opalińska, Aleksandra
Burdacki, Adrian
Kwaśniak, Konrad
Pogoda, Katarzyna
Tabarkiewicz, Jacek
Reich, Adam
author_sort Opalińska, Aleksandra
collection PubMed
description In the first part of this article, the anonymous patient diagnosed with leukocyte adhesion deficiency type 1 (LAD-1) and pyoderma gangrenosum (PG) discusses her experience of her medical history and treatment in a foreign country during her pregnancy and the coronavirus disease-19 (COVID-19) pandemic. The patient’s dermatologists, immunologist, and diagnostician refer to the epidemiology, genetics, diagnosis, morphologic manifestations, including skin lesions, treatment, and prognosis in LAD-1. The patient’s diagnostic and therapeutic process was discussed in the last part of this paper. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13555-021-00507-x.
format Online
Article
Text
id pubmed-7939102
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-79391022021-03-09 Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience Opalińska, Aleksandra Burdacki, Adrian Kwaśniak, Konrad Pogoda, Katarzyna Tabarkiewicz, Jacek Reich, Adam Dermatol Ther (Heidelb) Commentary In the first part of this article, the anonymous patient diagnosed with leukocyte adhesion deficiency type 1 (LAD-1) and pyoderma gangrenosum (PG) discusses her experience of her medical history and treatment in a foreign country during her pregnancy and the coronavirus disease-19 (COVID-19) pandemic. The patient’s dermatologists, immunologist, and diagnostician refer to the epidemiology, genetics, diagnosis, morphologic manifestations, including skin lesions, treatment, and prognosis in LAD-1. The patient’s diagnostic and therapeutic process was discussed in the last part of this paper. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13555-021-00507-x. Springer Healthcare 2021-03-08 /pmc/articles/PMC7939102/ /pubmed/33686591 http://dx.doi.org/10.1007/s13555-021-00507-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Commentary
Opalińska, Aleksandra
Burdacki, Adrian
Kwaśniak, Konrad
Pogoda, Katarzyna
Tabarkiewicz, Jacek
Reich, Adam
Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience
title Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience
title_full Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience
title_fullStr Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience
title_full_unstemmed Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience
title_short Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience
title_sort pyoderma gangrenosum with an underlying leukocyte adhesion deficiency type 1 (lad-1) and pregnancy in the shade of covid-19 epidemic: a patient and physician experience
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939102/
https://www.ncbi.nlm.nih.gov/pubmed/33686591
http://dx.doi.org/10.1007/s13555-021-00507-x
work_keys_str_mv AT opalinskaaleksandra pyodermagangrenosumwithanunderlyingleukocyteadhesiondeficiencytype1lad1andpregnancyintheshadeofcovid19epidemicapatientandphysicianexperience
AT burdackiadrian pyodermagangrenosumwithanunderlyingleukocyteadhesiondeficiencytype1lad1andpregnancyintheshadeofcovid19epidemicapatientandphysicianexperience
AT kwasniakkonrad pyodermagangrenosumwithanunderlyingleukocyteadhesiondeficiencytype1lad1andpregnancyintheshadeofcovid19epidemicapatientandphysicianexperience
AT pogodakatarzyna pyodermagangrenosumwithanunderlyingleukocyteadhesiondeficiencytype1lad1andpregnancyintheshadeofcovid19epidemicapatientandphysicianexperience
AT tabarkiewiczjacek pyodermagangrenosumwithanunderlyingleukocyteadhesiondeficiencytype1lad1andpregnancyintheshadeofcovid19epidemicapatientandphysicianexperience
AT reichadam pyodermagangrenosumwithanunderlyingleukocyteadhesiondeficiencytype1lad1andpregnancyintheshadeofcovid19epidemicapatientandphysicianexperience

Ejemplares similares